Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study

Patients undergoing hemodialysis with iron deficiency anemia (IDA) receiving treatment with erythropoiesis-stimulating agents (ESAs) who were intolerant or non-responsive to intravenous (i.v.) ferric gluconate (FG) (hemoglobin; Hb values < 10.5 g/dL or increase in <1 g/dL) or % transferrin sat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosati, Alberto, Conti, Paolo, Berto, Patrizia, Molinaro, Sabrina, Baldini, Federica, Egan, Colin Gerard, Panichi, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506237/
https://www.ncbi.nlm.nih.gov/pubmed/36142929
http://dx.doi.org/10.3390/jcm11185284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506237/
https://www.ncbi.nlm.nih.gov/pubmed/36142929
http://dx.doi.org/10.3390/jcm11185284

Ejemplares similares